Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aravive Biologics
Biotech
Aravive, weeks from liquidation, lays off 70% of its staff
The cash-strapped biotech has “several weeks” to find a partner or funding—and is laying off 70% of its staff to preserve what money it has left.
Nick Paul Taylor
Aug 22, 2023 8:50am
Phase 3 cancer flop blows hole in plans of cast-strapped Aravive
Aug 3, 2023 5:15am
Immunomedics taps Ipsen exec Semerjian as CEO—Chutes & Ladders
Apr 10, 2020 9:30am
Ray Tabibiazar departs Aravive to head development at Twist
Oct 24, 2018 10:48am
Aravive reveals near-death Versartis merger deal
Jun 4, 2018 9:12am
Seattle Genetics names Keytruda developer CMO—Chutes and Ladders
May 18, 2018 9:30am
